Literature DB >> 30884195

Transscleral sutureless intraocular lens versus retropupillary iris-claw lens fixation for paediatric aphakia without capsular support: a randomized study.

Asmaa Mahmoud Shuaib1, Yasmine El Sayed1, Ahmed Kamal1, Zeinab El Sanabary1, Hala Elhilali1.   

Abstract

PURPOSE: To compare results of sutureless transscleral intraocular lens (IOL) fixation to retropupillary iris-claw lens implantation in cases of paediatric aphakia without capsular support.
METHODS: Thirty eyes of children with insufficient capsular support for IOL implantation were randomized to undergo sutureless transscleral IOL fixation or iris-claw lens fixation. The primary outcome was best-corrected visual acuity (BCVA). Secondary outcomes included operative time, astigmatism, central corneal thickness, endothelial cell count (ECC), IOL decentration and tilt, central foveal thickness and complications.
RESULTS: There was a significant improvement in BCVA at all follow-up visits, with no significant difference between both groups. 53.3% in the transscleral-fixated IOL group and 80% in the iris-claw IOL group had a final BCVA ≥0.3. The operative time was significantly shorter in the iris-claw IOL group (p = 0.001). IOL decentration and tilt were higher in the transscleral-fixated IOL group, but the difference was not significant. The ECC was reduced by 14.6% in the transscleral-fixated IOL group and 11% in the iris-claw group at 6 months, with no significant difference between both groups (p = 0.5). In the transscleral-fixated IOL group, two eyes developed ocular hypertension and two eyes had IOL decentration, while in the iris-claw IOL group, 1 eye developed glaucoma, three eyes had haptic disenclavation, and one eye had retinal detachment.
CONCLUSION: Both techniques yielded a comparable visual outcome. Retropupillary iris-claw lens fixation is a shorter procedure and technically easier than sutureless transscleral fixation, but the risk of disenclavation should be considered especially in younger age groups. Scleral fixation is the only option in case of severe iris damage, but may be associated with more endothelial cell loss.
© 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  iris-claw lens; paediatric aphakia; retropupillary; sutureless scleral fixation

Mesh:

Year:  2019        PMID: 30884195     DOI: 10.1111/aos.14090

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Scleral fixation of subluxated or dislocated multifocal and multifocal toric intraocular lenses.

Authors:  Seo Yeon Park; Youngsub Eom; Young Joo Lee; Young Choi; Seong-Jae Kim; Jong Suk Song; Hyo Myung Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-24       Impact factor: 3.117

2.  Tilt and decentration of posterior and anterior iris-claw intraocular lenses: a pilot study using anterior segment optical coherence tomography.

Authors:  Giacomo Calzetti; Carlo Bellucci; Salvatore Antonio Tedesco; Maurizio Rossi; Stefano Gandolfi; Paolo Mora
Journal:  BMC Ophthalmol       Date:  2022-05-23       Impact factor: 2.086

3.  Long-term surgical outcomes of primary retropupillary iris claw intraocular lens implantation for the treatment of intraocular lens dislocation.

Authors:  Eun Young Choi; Chul Hee Lee; Hyun Goo Kang; Jae Yong Han; Suk Ho Byeon; Sung Soo Kim; Hyoung Jun Koh; Min Kim
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 4.  Surgical Management of Paediatric Aphakia in the Absence of Sufficient Capsular Support.

Authors:  Evdoxia-Maria Karasavvidou; Craig Wilde; Anwar Zaman; Gavin Orr; Dharmalingam Kumudhan; Georgios D Panos
Journal:  J Ophthalmol       Date:  2021-12-04       Impact factor: 1.909

Review 5.  Cataract management in children: a review of the literature and current practice across five large UK centres.

Authors:  J E Self; R Taylor; A L Solebo; S Biswas; M Parulekar; A Dev Borman; J Ashworth; R McClenaghan; J Abbott; E O'Flynn; D Hildebrand; I C Lloyd
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.